Instrument
🇰🇷 Samsung Biologics
KR (Korea) · 207940 · 삼성바이오로직스
Today's Score
0.58
neutral (yesterday 0.66)30-day score trend
📊 Quant score trend
Last 30d quant score (PER/PBR/ROE/debt/margin/growth sector percentile)
PER 43.5 / PBR 8.70 / ROE 19.4% / 부채비율 48% / 이익률 45.4% / 매출성장 +30.3% / 이익성장 +64.7%
Not a buy or sell signal. Informational only.
📊 Latest earnings — 2026-06-30
Revenue
1.3T
YoY -20.4%
QoQ +5.1%
Operating income
586.4B
YoY -19.5%
Net income
—
YoY —
Informational — not a buy signal. Source: DART
🕸️ Metrics radar
Each axis is 0-100. Higher means stronger on that dimension.
Informational — 5 axes are 0-100 percentile, compared to sector average
Market regime — 🇰🇷 KR (Korea)
BULL "이번 주 +10.8%, 추세는 살아 있습니다. 분위기는 들떠 있어요."
📈 7-day price
📋 Recent filings (DART)
- 08-14 지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
- 08-14 반기보고서 (2026.06)
- 08-06 임원ㆍ주요주주특정증권등소유상황보고서
Source: DART (Korean electronic disclosure). Reference only.
📰 Recent news
-
코스피 6700선 무너졌다…삼성전자 8.69% 급락
08-24 · Naver
-
[코스피 지수선물 옵션] 삼성전자 급락 속 고려아연·삼성SDI 강세
08-24 · Naver
-
삼성전자 실망 매물 폭탄에…코스피 6700선 아래로
08-24 · Naver
Source: Naver. Not Tradory's opinion.
🔎 Compare info
Click a button to see database-backed metrics. Informational only, not buy or sell signals.
ⓘ This compares public financial and market data. Not a buy or sell opinion.
See more after signing up
- • 5-year full chart (D/W/M/Y + RSI/MACD)
- • DCA simulation + market index comparison
- • Watchlist + email alerts
ⓘ Informational summary, not a buy or sell signal. Past data does not guarantee future returns.